查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1762248

生物標記發現外包服務市場、規模、佔有率、趨勢、行業分析報告：依類型、治療領域、發現階段、最終用途、地區、市場預測2025-2034

Biomarker Discovery Outsourcing Services Market Size, Share, Trends, Industry Analysis Report: By Type, Therapeutic Area, Discovery Phase, End Use, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，全球生物標記發現外包服務市場預計到2034年將達到 839.3億美元。本研究報告對當前的市場動態提供了詳細的見解，並對未來的市場成長進行了分析。

生物標記發現外包服務包括與第三方簽訂合約，以識別、驗證和開發在疾病診斷、藥物開發和個人化醫療中發揮重要作用的生物標誌物。此類服務由合約研究組織（CRO）、生物技術公司和專業實驗室提供，為製藥和醫療保健公司提供下一代定序、蛋白質組學和生物資訊學等先進技術。外包生物標記發現可以幫助公司最佳化研發（R&D）效率、降低營運成本並加快新療法的上市時間。隨著對精準醫療和標靶治療的日益關注，對此類服務的需求顯著增加，因為生物標記可以幫助識別患者對治療的特定反應並提高臨床試驗的成功率。由於研究合作的增加、醫療保健投資的增加以及基於生物標誌物的診斷技術的進步，生物標誌物發現外包服務市場穩步成長。

由於技術進步、強勁的製藥業和支持性的監管框架，生物標誌物發現外包服務市場經歷顯著成長。關鍵驅動因素包括日益採用人工智慧（AI）和機器學習來增強生物標記分析，以及擴大服務組合以滿足多樣化的研究需求。開發商也優先考慮與藥物開發商建立策略聯盟，以提高效率和競爭力。人們對個人化醫療和生物標記驅動的藥物開發的日益關注進一步加速市場發展，為疾病檢測和治療最佳化方面的創新解決方案創造了機會。隨著精準醫療需求的成長，提供推動生物醫學研究和治療發展的尖端工具和服務的市場將持續發展。

生物標記發現外包服務市場報告重點

依類型劃分，替代終點佔據最大的市場佔有率。替代終點可作為臨床結果的間接衡量指標，使研究人員能夠在藥物開發過程中更有效地評估治療的療效和安全性。

基於治療領域，腫瘤學佔據生物標記發現外包服務市場主導地位。這是由於癌症發病率不斷上升以及生物標記驅動的藥物開發的日益普及。生物標記在早期癌症檢測、預後預測和治療選擇的應用增加了該領域在臨床研究中的重要性。

北美佔有最大的市場佔有率。這一優勢源於對研發的大量投資、對精準醫療的關注以及製藥公司和合約研究組織（CRO）之間的密切合作。

生物標記發現外包服務市場預計將以亞太地區最高的年複合成長率成長。這種快速擴張可以歸因於製藥公司研發活動的增加、臨床試驗活動的激增以及中國和印度等國家提供的經濟高效的外包解決方案。

生物標記發現外包服務市場的主要參與者包括Laboratory Corporation of America Holdings（Labcorp）、Charles River Laboratories International, Inc.、Eurofins Scientific、Celerion、ICON plc、Parexel International（MA）Corporation、Proteome Sciences、Thermo Fisher Scientific Inc.、Evotec、WuXi AppTec、GenScript ProBio、Fujirebio Holdings Inc.。

目錄

第1章 簡介

第2章 執行摘要

第3章 研究方法

第4章 全球生物標記發現外包服務市場洞察

  • 市場概況
  • 生物標記發現外包服務市場動態
    • 驅動因素和機會
      • 慢性病盛行率不斷上升
      • 組學技術的進步
    • 抑制因素和挑戰
      • 生物標記驗證的成本高且複雜
  • PESTEL 分析
  • 生物標記發現外包服務市場趨勢
  • 價值鏈分析
  • COVID-19 影響分析

第5章 全球生物標記發現外包服務市場（依類型）

  • 主要調查結果
  • 簡介
  • 預測性生物標記
  • 預後生物標記
  • 安全生物標記
  • 替代端點

第6章 全球生物標記發現外包服務市場（依治療領域）

  • 主要調查結果
  • 簡介
  • 腫瘤學
  • 神經病學
  • 心臟病學
  • 自體免疫疾病
  • 其他

第7章 全球生物標記發現外包服務市場（依發現階段）

  • 主要調查結果
  • 簡介
  • 生物標記識別
  • 生物標記驗證
  • 生物標記分析
  • 生物標記組開發
  • 生物標記選擇

第8章 全球生物標記發現外包服務市場（依最終用途）

  • 主要調查結果
  • 簡介
  • 製藥公司
  • 生技公司
  • 其他

第9章 全球生物標記發現外包服務市場（依地區）

  • 主要調查結果
  • 簡介
    • 生物標記發現外包服務市場評估：地區，2020-2034
  • 北美
    • 北美：依類型，2020-2034年
    • 北美：依治療領域，2020-2034年
    • 北美：依發現階段，2020-2034年
    • 北美：依最終用途，2020-2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲：依類型，2020-2034年
    • 歐洲：依治療領域，2020-2034年
    • 歐洲：依發現階段，2020-2034年
    • 歐洲：依最終用途，2020-2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 亞太地區：依類型，2020-2034年
    • 亞太地區：依治療領域，2020-2034年
    • 亞太地區：依發現階段，2020-2034年
    • 亞太地區：依最終用途，2020-2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東和非洲
    • 中東和非洲：依類型，2020-2034年
    • 中東和非洲：依治療領域，2020-2034年
    • 中東和非洲：依發現階段，2020-2034年
    • 中東和非洲：依最終用途，2020-2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲地區
  • 拉丁美洲
    • 拉丁美洲：依類型，2020-2034年
    • 拉丁美洲：依治療領域，2020-2034年
    • 拉丁美洲：依發現階段，2020-2034年
    • 拉丁美洲：依最終用途，2020-2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家

第10章 競爭格局

  • 擴張與收購分析
    • 擴張
    • 收購
  • 夥伴關係/協作/協議/公開

第11章 公司簡介

  • Celerion
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific
  • Evotec
  • Fujirebio Holdings Inc.
  • GenScript ProBio
  • ICON plc
  • Laboratory Corporation of America Holdings（Labcorp）
  • Parexel International（MA）Corporation
  • Proteome Sciences
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec
Product Code: PM4075

The global biomarker discovery outsourcing services market size is expected to reach USD 83.93 billion by 2034, according to a new study by Polaris Market Research. The report "Biomarker Discovery Outsourcing Services Market Size, Share, Trends, Industry Analysis Report: By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers, and Surrogate Endpoints), Therapeutic Area, Discovery Phase, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Biomarker discovery outsourcing services involve contracting third-party organizations to identify, validate, and develop biomarkers that play a crucial role in disease diagnosis, drug development, and personalized medicine. These services are offered by contract research organizations (CROs), biotechnology firms, and specialized laboratories, providing pharmaceutical and healthcare companies access to advanced technologies such as next-generation sequencing, proteomics, and bioinformatics. By outsourcing biomarker discovery, companies can optimize research and development (R&D) efficiency, reduce operational costs, and accelerate the time-to-market for new therapies. The growing focus on precision medicine and targeted therapies has significantly increased the demand for these services, as biomarkers help in identifying patient-specific responses to treatments and improving clinical trial success rates. The biomarker discovery outsourcing services market is witnessing steady growth due to increasing research collaborations, rising healthcare investments, and advancements in biomarker-based diagnostics.

The biomarker discovery outsourcing services market is experiencing significant growth, fueled by advancements in technology, a robust pharmaceutical sector, and supportive regulatory frameworks. Key drivers include the increasing adoption of artificial intelligence (AI) and machine learning to enhance biomarker analysis, as well as the expansion of service portfolios to meet diverse research needs. Companies are also prioritizing strategic collaborations with drug developers to improve efficiency and competitiveness. The rising focus on personalized medicine and biomarker-driven drug development is further accelerating market expansion, creating opportunities for innovative solutions in disease detection and treatment optimization. As demand for precision medicine grows, the market is poised for continued progress, offering cutting-edge tools and services to advance biomedical research and therapeutic development.

Biomarker Discovery Outsourcing Services Market Report Highlights

By type, surrogate endpoints hold the largest market share. Surrogate endpoints serve as indirect measures representing clinical outcomes, enabling researchers to assess treatment efficacy and safety more efficiently during drug development.

By therapeutic area, oncology dominates the biomarker discovery outsourcing services market, driven by the increasing prevalence of cancer and the growing adoption of biomarker-driven drug development. The use of biomarkers in early cancer detection, prognosis, and treatment selection enhances the segment's significance in clinical research.

North America holds the largest market share. This dominance is driven by substantial R&D investments, a strong emphasis on precision medicine, and robust collaborations between pharmaceutical companies and contract research organizations (CROs).

Asia Pacific is experiencing the highest biomarker discovery outsourcing services market CAGR. This rapid expansion is attributed to increasing pharmaceutical R&D activities, a surge in clinical trial operations, and cost-effective outsourcing solutions available in countries such as China and India.

The biomarker discovery outsourcing services market key players include Laboratory Corporation of America Holdings (Labcorp), Charles River Laboratories International, Inc., Eurofins Scientific, Celerion, ICON plc, Parexel International (MA) Corporation, Proteome Sciences, Thermo Fisher Scientific Inc., Evotec, WuXi AppTec, GenScript ProBio, and Fujirebio Holdings Inc

Polaris Market Research has segmented biomarker discovery outsourcing services market report based on type, therapeutic area, discovery phase, end use, and region:

By Type Outlook (Revenue-USD Billion, 2020-2034)

Predictive Biomarkers

Prognostic Biomarkers

Safety Biomarkers

Surrogate Endpoints

By Therapeutic Area Outlook (Revenue-USD Billion, 2020-2034)

Oncology

Neurology

Cardiology

Autoimmune Diseases

Others

By Discovery Phase Outlook (Revenue-USD Billion, 2020-2034)

Biomarker Identification

Biomarker Validation

Biomarker Profiling

Biomarker Panel Development

Biomarker Selection

By End Use Outlook (Revenue-USD Billion, 2020-2034)

Pharmaceutical Companies

Biotechnology Companies

Others

By Regional Outlook (Revenue-USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

Suth Korea

Indnesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

Suth Africa

Rest of Middle East & Africa

Latin America

Mexic

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Biomarker Discovery Outsourcing Services Market Insights

  • 4.1. Biomarker Discovery Outsourcing Services Market - Market Snapshot
  • 4.2. Biomarker Discovery Outsourcing Services Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Chronic Diseases
      • 4.2.1.2. Advancements in Omics Technologies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost and complexity of biomarker validation
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Biomarker Discovery Outsourcing Services Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Biomarker Discovery Outsourcing Services Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Predictive biomarkers
    • 5.3.1. Global Biomarker Discovery Outsourcing Services Market, by Predictive biomarkers, by Region, 2020-2034 (USD Billion)
  • 5.4. Prognostic biomarkers
    • 5.4.1. Global Biomarker Discovery Outsourcing Services Market, by Prognostic biomarkers, by Region, 2020-2034 (USD Billion)
  • 5.5. Safety biomarkers
    • 5.5.1. Global Biomarker Discovery Outsourcing Services Market, by Safety biomarkers, by Region, 2020-2034 (USD Billion)
  • 5.6. Surrogate endpoints
    • 5.6.1. Global Biomarker Discovery Outsourcing Services Market, by Surrogate endpoints, by Region, 2020-2034 (USD Billion)

6. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 6.3. Oncology
    • 6.3.1. Global Biomarker Discovery Outsourcing Services Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 6.4. Neurology
    • 6.4.1. Global Biomarker Discovery Outsourcing Services Market, by Neurology, by Region, 2020-2034 (USD Billion)
  • 6.5. Cardiology
    • 6.5.1. Global Biomarker Discovery Outsourcing Services Market, by Cardiology, by Region, 2020-2034 (USD Billion)
  • 6.6. Autoimmune Diseases
    • 6.6.1. Global Biomarker Discovery Outsourcing Services Market, by Autoimmune Diseases, by Region, 2020-2034 (USD Billion)
  • 6.7. Others
    • 6.7.1. Global Biomarker Discovery Outsourcing Services Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • 7.3. Biomarker Identification
    • 7.3.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Identification, by Region, 2020-2034 (USD Billion)
  • 7.4. Biomarker Validation
    • 7.4.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Validation, by Region, 2020-2034 (USD Billion)
  • 7.5. Biomarker Profiling
    • 7.5.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Profiling, by Region, 2020-2034 (USD Billion)
  • 7.6. Biomarker Panel Development
    • 7.6.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Panel Development, by Region, 2020-2034 (USD Billion)
  • 7.7. Biomarker Selection
    • 7.7.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Selection, by Region, 2020-2034 (USD Billion)

8. Global Biomarker Discovery Outsourcing Services Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 8.3. Pharmaceutical Companies
    • 8.3.1. Global Biomarker Discovery Outsourcing Services Market, by Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)
  • 8.4. Biotechnology Companies
    • 8.4.1. Global Biomarker Discovery Outsourcing Services Market, by Biotechnology Companies, by Region, 2020-2034 (USD Billion)
  • 8.5. Others
    • 8.5.1. Global Biomarker Discovery Outsourcing Services Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Biomarker Discovery Outsourcing Services Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Biomarker Discovery Outsourcing Services Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Biomarker Discovery Outsourcing Services Market - North America
    • 9.3.1. North America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.3.2. North America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.3.3. North America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.3.4. North America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.3.5. Biomarker Discovery Outsourcing Services Market - US
      • 9.3.5.1. US: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.3.5.2. US: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.3.5.3. US: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.3.5.4. US: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.3.6. Biomarker Discovery Outsourcing Services Market - Canada
      • 9.3.6.1. Canada: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.4. Biomarker Discovery Outsourcing Services Market - Europe
    • 9.4.1. Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.5. Biomarker Discovery Outsourcing Services Market - UK
      • 9.4.5.1. UK: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.6. Biomarker Discovery Outsourcing Services Market - France
      • 9.4.6.1. France: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.7. Biomarker Discovery Outsourcing Services Market - Germany
      • 9.4.7.1. Germany: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.8. Biomarker Discovery Outsourcing Services Market - Italy
      • 9.4.8.1. Italy: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.9. Biomarker Discovery Outsourcing Services Market - Spain
      • 9.4.9.1. Spain: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.10. Biomarker Discovery Outsourcing Services Market - Netherlands
      • 9.4.10.1. Netherlands: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.11. Biomarker Discovery Outsourcing Services Market - Russia
      • 9.4.11.1. Russia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.4.12. Biomarker Discovery Outsourcing Services Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.5. Biomarker Discovery Outsourcing Services Market - Asia Pacific
    • 9.5.1. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.5. Biomarker Discovery Outsourcing Services Market - China
      • 9.5.5.1. China: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.6. Biomarker Discovery Outsourcing Services Market - India
      • 9.5.6.1. India: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.7. Biomarker Discovery Outsourcing Services Market - Malaysia
      • 9.5.7.1. Malaysia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.8. Biomarker Discovery Outsourcing Services Market - Japan
      • 9.5.8.1. Japan: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.9. Biomarker Discovery Outsourcing Services Market - Indonesia
      • 9.5.9.1. Indonesia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.10. Biomarker Discovery Outsourcing Services Market - South Korea
      • 9.5.10.1. South Korea: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.11. Biomarker Discovery Outsourcing Services Market - Australia
      • 9.5.11.1. Australia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.5.12. Biomarker Discovery Outsourcing Services Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.6. Biomarker Discovery Outsourcing Services Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.5. Biomarker Discovery Outsourcing Services Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.6. Biomarker Discovery Outsourcing Services Market - UAE
      • 9.6.6.1. UAE: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.7. Biomarker Discovery Outsourcing Services Market - Israel
      • 9.6.7.1. Israel: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.8. Biomarker Discovery Outsourcing Services Market - South Africa
      • 9.6.8.1. South Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.6.9. Biomarker Discovery Outsourcing Services Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.7. Biomarker Discovery Outsourcing Services Market - Latin America
    • 9.7.1. Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.5. Biomarker Discovery Outsourcing Services Market - Mexico
      • 9.7.5.1. Mexico: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.6. Biomarker Discovery Outsourcing Services Market - Brazil
      • 9.7.6.1. Brazil: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.7. Biomarker Discovery Outsourcing Services Market - Argentina
      • 9.7.7.1. Argentina: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
    • 9.7.8. Biomarker Discovery Outsourcing Services Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Celerion
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Charles River Laboratories International, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Eurofins Scientific
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Evotec
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Fujirebio Holdings Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. GenScript ProBio
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. ICON plc
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Laboratory Corporation of America Holdings (Labcorp)
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Parexel International (MA) Corporation
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Proteome Sciences
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Thermo Fisher Scientific Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. WuXi AppTec
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development

List of Tables:

  • Table 1 Global Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 3 Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 4 Global Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 5 North America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 6 North America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 7 North America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 8 North America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 9 U.S.: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 10 U.S.: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 11 U.S.: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 12 U.S.: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 Canada: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 14 Canada: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 15 Canada: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 16 Canada: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 17 Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 18 Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 19 Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 20 Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 21 UK: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 22 UK: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 23 UK: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 24 UK: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 France: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 26 France: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 27 France: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 28 France: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 29 Germany: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 30 Germany: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 31 Germany: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 32 Germany: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 33 Italy: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 34 Italy: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 35 Italy: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 36 Italy: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Spain: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Spain: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 39 Spain: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 40 Spain: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 41 Netherlands: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 42 Netherlands: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 43 Netherlands: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 44 Netherlands: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 45 Russia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 46 Russia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 47 Russia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 48 Russia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 57 China: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 58 China: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 59 China: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 60 China: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 India: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 62 India: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 63 India: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 64 India: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 65 Malaysia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 66 Malaysia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 67 Malaysia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 68 Malaysia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 69 Japan: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 70 Japan: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 71 Japan: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 72 Japan: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 73 Indonesia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 74 Indonesia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 75 Indonesia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 76 Indonesia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 77 South Korea: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 78 South Korea: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 79 South Korea: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 80 South Korea: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 81 Australia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 82 Australia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 83 Australia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 84 Australia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 97 UAE: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 98 UAE: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 99 UAE: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 100 UAE: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 101 Israel: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 102 Israel: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 103 Israel: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 104 Israel: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 105 South Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 106 South Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 107 South Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 108 South Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 113 Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 114 Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 115 Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 116 Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 117 Mexico: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 118 Mexico: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 119 Mexico: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 120 Mexico: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 121 Brazil: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 122 Brazil: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 123 Brazil: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 124 Brazil: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 125 Argentina: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 126 Argentina: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 127 Argentina: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 128 Argentina: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Biomarker Discovery Outsourcing Services Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Biomarker Discovery Outsourcing Services Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Therapeutic Area
  • Figure 9. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Discovery Phase
  • Figure 11. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2024 & 2034 (USD Billion)
  • Figure 12. Market by End Use
  • Figure 13. Global Biomarker Discovery Outsourcing Services Market, by End Use, 2024 & 2034 (USD Billion)